Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **linoleic acid metabolism pathway** refers to the series of biochemical processes by which linoleic acid, an essential omega-6 polyunsaturated fatty acid, is enzymatically converted into longer chain and more highly unsaturated fatty acids such as gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), and arachidonic acid (AA), as well as various biologically active lipid mediators, including prostaglandins, leukotrienes, and endocannabinoids. These metabolites are critical in regulating inflammation, immune response, and cellular signaling. Dysregulation of this pathway is implicated in diseases such as cardiovascular disease, metabolic syndrome, cancer, and inflammatory disorders. Enzymes involved include delta-6 desaturase, elongases, cyclooxygenases, lipoxygenases, and cytochrome P450s[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Linoleic acid metabolism pathway.